Study of effects of antiglaucoma eye drops on N-methyl-D-aspartate-induced retinal damage

Japanese Journal of Ophthalmology

Volumn 49, Issue 6, 2005, Pages 453-461

  Metoki, Tomomi ^a   Ohguro, Hiroshi ^a   Ohguro, Ikuyo ^a   Mamiya, Kazuhisa ^a   Ito, Tadashi ^a   Nakazawa, Mitsuru ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Animal model; Antiglaucoma drug; DNA microarray; Glaucoma; N methyl D aspartate

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIGLAUCOMA AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BRIMONIDINE; BUNAZOSIN; CARTEOLOL; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EYE DROPS; GLIAL FIBRILLARY ACIDIC PROTEIN; LATANOPROST; LEVOBUNOLOL; N METHYL DEXTRO ASPARTIC ACID; NIPRADILOL; PROSTAGLANDIN DERIVATIVE; SOMATOMEDIN C; TIMOLOL;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLAUCOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA GANGLION CELL; RETINA INJURY; UPREGULATION;

ADRENERGIC ANTAGONISTS; ANIMALS; ANTIHYPERTENSIVE AGENTS; DISEASE MODELS, ANIMAL; GLIAL FIBRILLARY ACIDIC PROTEIN; N-METHYLASPARTATE; OPHTHALMIC SOLUTIONS; RATS; RATS, INBRED LEW; RETINAL DISEASES; RETINAL GANGLION CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TREATMENT OUTCOME; UP-REGULATION;

EID: 29244438147     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10384-005-0253-5     Document Type: Article

References (46)

1. DW Choi SM Rothman 1990 The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death Annu Rev Neurosci 13 171 182
2. JW Olney 1990 Excitotoxic amino acids and neuropsychiatric disorders Annu Rev Pharmacol 30 47 71
3. SM Rothman JW Olney 1986 Glutamate and the pathophysiology of hypoxic/ischemic brain damage Ann Neurol 19 105 111
4. LA Levin A Louhab 1996 Apoptosis of retinal ganglion cells in anterior ischemic optic neuropathy Arch Ophthalmol 114 488 491
5. HA Quigley RW Nickells LA Kerrigan ME Pease DJ Thibault DJ Zack 1995 Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis Invest Ophthalmol Vis Sci 36 774 786
6. EB Dreyer D Zurakowski RA Schumer SM Podos SA Lipton 1997 Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma Arch Ophthalmol 114 299 305
7. E Garcia-Valenzuela S Shareef J Walsh SC Sharman 1995 Programmed cell death of retinal ganglion cells during experimental glaucoma Exp Eye Res 61 33 44
8. LA Kerrigan DJ Zack HA Quigley SD Smith ME Pease 1997 TUNEL-positive ganglion cells in human primary open-angle glaucoma Arch Ophthalmol 115 1031 1035
9. M Honjo H Tanihara N Kido M Inatani K Okazaki Y Honda 2000 Expression of ciliary neurotrophic factor activated by retinal Müller cells in eyes with NMDA- and kainic acid-induced neuronal death Invest Ophthalmol Vis Sci 41 552 560
10. TT Larn AS Abler JMK Kwong MOM Tso 1999 N-Methyl-d-aspartate (NMDA)-induced apoptosis in rat retina Invest Ophthalmol Vis Sci 40 2391 2397
11. R Siliprandi R Canella G Carmingnoto 1992 N-Methyl-d-aspartate-induced neurotoxicity in the adult rat retina Vis Neurosci 8 567 573
12. I Maruyama T Maeda S Okisaka A Mizukawa M Nakazawa H Ohguro 2002 Autoantibody against neuron-specific enolase found in glaucoma patients causes retinal dysfunction in vivo Jpn J Ophthalmol 46 1 12
13. NN Osbome C Cazevieille AL Carvalho AK Larsen L DeSantis 1997 In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent Brain Res 751 113 123
14. RL Gross SH Hensley F Gao SM Wu 1999 Retinal ganglion cell dysfunction induced by hypoxia and glutamate: potential neuroprotective effects of β-blockers Surv Ophthalmol 43 162 170
15. K Mizuno T Koide M Yoshimura M Araie 2001 Neuroprotective effect and intraocular penetration of nipradilol, αβ-blocker with nitric oxide donative action Invest Ophthalmol Vis Sci 42 688 694
16. K Mizuno T Koide N Saito 2002 Topical nipradilol: effects on optic nerve head circulation in humans and periocular distribution in monkeys Invest Ophthalmol Vis Sci 43 3243 3250
17. T Ito H Ohguro I Ohguro 2004 Change of retinal ganglion cells in the ocular hypertension model rat Hirosaki Med J 56 15 20
18. I Maruyama H Ohguro Y Ikeda 2000 Retinal ganglion cells recognized by serum autoantibody against γ-enolase found in glaucoma patients Invest Ophthalmol Vis Sci 41 1657 1665
19. I Maruyama Y Ikeda M Nakazawa H Ohguro 2000 Clinical roles of autoantibody against neuron-specific enolase in glaucoma patients Tohoku J Exp Med 197 125 132
20. 3H] noradrenaline to bovine membrane of the retina. Evidence for the existence of alpha 2-receptors Vision Res 22 1401 1407
21. MA Zarbin JK Wamsley JM Palacios MJ Kuhar 1986 Autoradiographic localization of high affinity GABA, benzodiazepine, dopaminergic adrenergic and muscarinic cholinergic receptors in the rat, monkey and human retina Brain Res 374 75 92
22. R Wen T Cheng Y Li W Cao RH Steinberg 1996 α2-Adrenergic agonists induce basic fibroblast growth factor expression in photoreceptor in vivo and ameliorate light damage J Neurosci 16 5986 5992
23. E Yoles LA Wheeler M Schwartz 1999 α2-Adrenenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration Invest Ophthalmol Vis Sci 40 65 73
24. MP Lafuente MP Villegas-Perez P Sobrado-Calvo 2001 Neuroprotective effects of α2-selective adrenergic agonists against ischemia induced retinal ganglion cell death Invest Ophthalmol Vis Sci 42 2074 2084
25. LA Wheeler E WoldeMussie 2001 alpha-2 Adrenergic receptors are neuroprotective in experimental models of glaucoma Eur J Ophthalmol 11 30 35
26. LA Wheeler DW Gil E WoldeMussie 2001 Role of alpha-2 adrenergic receptors in neuroprotection and glaucoma Surv Ophthalmol 45 290 294
27. K Kashiwagi Y Iizuka S Tsukahara 2002 Neuroprotective effects of nipradilol on purified cultured retinal ganglion cells J Glaucoma 11 231 238
28. WO Salmon Jr WH Daughaday 1990 A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. 1956 J Lab Clin Med 116 408 419
29. WH Daughaday K Hall MS Raben WD Salmon Jr JL van den Brande JJ van Wyk 1972 Somatomedin: proposed designation for sulphation factor Nature 235 107
30. WH Daughaday P Rotwein 1989 Insulin-1ike growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations Endocr Rev 10 68 91
31. A Ullrich A Gray AW Tam 1986 Insulin-like growth factor I receptor primary structural comparison with insulin receptor suggests structure determinants that define functional specificity EMBO J 5 2503 2512
32. S Dore S Kar R Quinon 1997 Rediscovering an old friend, IGF-1: potential use in the treatment of neurodegenerative diseases Trends Neurosci 20 326 331
33. KD Beck BL Powell HR Widmer J Valverde F Hefti 1995 IGF-1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons Neuron 14 717 730
34. CE Stewart P Rotwein 1996 Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors Physiol Rev 76 1005 1026
35. P Kermer N Klöcker M Labes M Bahr 2000 Insulin-like growth factor-1 protects axotomized rat retinal ganglion cells from secondary death via P13-K-dependent Akt phosphorylation and inhibition of caspase-3 in vivo J Neurosci 20 722 728
36. A Ullrich J Schlessinger 1990 Signal transduction by receptors with tyrosine kinase activity Cell 61 203 212
37. T Wada X Qian MI Greene 1990 Intermolecular association of the pl85neu protein and EGF receptor modulates EGF receptor function Cell 61 1339 1347
38. MH Kraus W Issing T Miki NC Popescu SA Aaronson 1989 Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence of over expression in a subset for human mammary tumors Proc Natl Acad Sci U S A 86 9193 9197
39. erbB4, a fourth member of the epidermal growth factor receptor family Proc Natl Acad Sci U S A 90 1746 1750
40. K Flurkey M Stadecker RA Miller 1992 Memory T lymphocyte hyporesponsiveness to non-cognate stimuli: a key factor in age-related immunodeficiency Eur J Immunol 22 931 935
41. A Nandi P Estess MH Siegelman 2000 Hyaluronan anchoring and regulation on the surface of vascular endothelial cells is mediated through the functionally activated form of CD44 J Biol Chem 275 14939 14984
42. A Ariel O Lider A Brill L Cuhalon N Savion D Varon 2000 Induction of interactions between CD44 and hyaluronic acid by a short exposure of human T cells to diverse pro-inflammatory mediators Immunology 100 345 351
43. LS Sherman TA Rizvi S Karyala N Ratner 2000 CD44 enhances neuregulin signaling by Schwann cells J Cell Bio 150 1071 1084
44. MR Ehlers JF Riordan 1991 Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane protein Biochemistry 30 10065 10074
45. PA Knepper CSK Mayanil W Goossens 2002 Aqueous humor in primary open angle glaucoma contains an increased level of CD44S Invest Ophthalmol Vis Sci 43 133 139
46. U Gunthert B Johansson 2000 CD44: a protein family involved in autoimmune diseases and apoptosis Immunologist 8 106 109